6-143462894-ATT-AT
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003630.3(PEX3):c.206-14delT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.69 ( 36245 hom., cov: 0)
Exomes 𝑓: 0.64 ( 292704 hom. )
Consequence
PEX3
NM_003630.3 intron
NM_003630.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0500
Publications
1 publications found
Genes affected
PEX3 (HGNC:8858): (peroxisomal biogenesis factor 3) The product of this gene is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
PEX3 Gene-Disease associations (from GenCC):
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 10A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- peroxisome biogenesis disorder 10BInheritance: AR Classification: STRONG Submitted by: G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 6-143462894-AT-A is Benign according to our data. Variant chr6-143462894-AT-A is described in ClinVar as Benign. ClinVar VariationId is 259105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.774 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003630.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX3 | NM_003630.3 | MANE Select | c.206-14delT | intron | N/A | NP_003621.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX3 | ENST00000367591.5 | TSL:1 MANE Select | c.206-21delT | intron | N/A | ENSP00000356563.4 | |||
| PEX3 | ENST00000367592.5 | TSL:5 | c.74-21delT | intron | N/A | ENSP00000356564.1 |
Frequencies
GnomAD3 genomes AF: 0.687 AC: 104205AN: 151652Hom.: 36192 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
104205
AN:
151652
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.650 AC: 163046AN: 250758 AF XY: 0.639 show subpopulations
GnomAD2 exomes
AF:
AC:
163046
AN:
250758
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.636 AC: 911409AN: 1433936Hom.: 292704 Cov.: 0 AF XY: 0.632 AC XY: 452098AN XY: 715350 show subpopulations
GnomAD4 exome
AF:
AC:
911409
AN:
1433936
Hom.:
Cov.:
0
AF XY:
AC XY:
452098
AN XY:
715350
show subpopulations
African (AFR)
AF:
AC:
25918
AN:
32878
American (AMR)
AF:
AC:
32782
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
AC:
18112
AN:
25972
East Asian (EAS)
AF:
AC:
24159
AN:
39520
South Asian (SAS)
AF:
AC:
43516
AN:
85634
European-Finnish (FIN)
AF:
AC:
37176
AN:
53382
Middle Eastern (MID)
AF:
AC:
3631
AN:
5718
European-Non Finnish (NFE)
AF:
AC:
688544
AN:
1086774
Other (OTH)
AF:
AC:
37571
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
16207
32415
48622
64830
81037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18074
36148
54222
72296
90370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.687 AC: 104314AN: 151768Hom.: 36245 Cov.: 0 AF XY: 0.687 AC XY: 50975AN XY: 74180 show subpopulations
GnomAD4 genome
AF:
AC:
104314
AN:
151768
Hom.:
Cov.:
0
AF XY:
AC XY:
50975
AN XY:
74180
show subpopulations
African (AFR)
AF:
AC:
32302
AN:
41374
American (AMR)
AF:
AC:
11034
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
2423
AN:
3468
East Asian (EAS)
AF:
AC:
2845
AN:
5152
South Asian (SAS)
AF:
AC:
2397
AN:
4812
European-Finnish (FIN)
AF:
AC:
7405
AN:
10518
Middle Eastern (MID)
AF:
AC:
177
AN:
292
European-Non Finnish (NFE)
AF:
AC:
43679
AN:
67884
Other (OTH)
AF:
AC:
1429
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1622
3244
4865
6487
8109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1890
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Peroxisome biogenesis disorder 10B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Peroxisome biogenesis disorder 10A (Zellweger) Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Mar 03, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.